| Name | FOXY-5 |
|---|---|
| Synonyms |
FOXY-5
N-Formyl-L-methionyl-L-α-aspartylglycyl-L-cysteinyl-L-α-glutamyl-L-leucine CBZ9UL0ARB L-Leucine, N-formyl-L-methionyl-L-α-aspartylglycyl-L-cysteinyl-L-α-glutamyl- |
| Description | Foxy-5 is a mimicking peptide of WNT5A which is a non-canonical member of the Wnt family. Foxy-5 is a WNT5A agonist and effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model[1][2]. |
|---|---|
| Related Catalog | |
| Target |
WNT5A[1] |
| In Vivo | Foxy-5 effectively reduces the metastatic spread of WNT5A-low prostate cancer cells in an orthotopic mouse model[1]. Foxy-5 reduces the number of colonic cancer stem cells in a xenograft mouse model of human colonic cancer[2]. |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 1244.1±65.0 °C at 760 mmHg |
| Molecular Formula | C26H42N6O12S2 |
| Molecular Weight | 694.775 |
| Flash Point | 706.2±34.3 °C |
| Exact Mass | 694.230225 |
| LogP | 0.62 |
| Vapour Pressure | 0.0±0.6 mmHg at 25°C |
| Index of Refraction | 1.562 |